SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: E.J. Neitz Jr who wrote (6363)5/26/1998 8:42:00 PM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Ed, June issue of Taipan carries kind words for XOMA. Nothing we don't know but once again demonstrates that XOMA has support among various letter writers. Last time I believe we posted 7 letters or advisors recommending XOMA.

BTW another new patent not covered in XOMA web page announcement. 5,756,699 on Ribosome Inactivating Proteins. This is similar to a prior patent and perhaps is part of the out-licensing program. In the XOMA press release 5756464 & 5753620. Patent 5,756,699 also happened to be issued on 26 May.



To: E.J. Neitz Jr who wrote (6363)5/27/1998 12:34:00 AM
From: Tharos  Read Replies (2) | Respond to of 17367
 
Ed,
It was a down day, Xoma closed lower than it opened.
Volume was 38% of normal.
You have me curious about your definition of "impressive technical action."


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News